Skye Bioscience, Inc. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
Skye Bioscience, Inc. (SKYE) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $925.55 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2025-03-20
- Skye Bioscience, Inc. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2023-09-30 was $925.55K.
- Skye Bioscience, Inc. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2023 was $925.55K.
- Skye Bioscience, Inc. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2017 was $175.00K, a 46.15% decline from fiscal 2016.
- Skye Bioscience, Inc. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2016 was $325.00K.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|---|
| 2023-12-31 | $925.55K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $925.55K 10-Q · filed 2023-11-14 | |
| 2017-12-31 | $175.00K 10-K · filed 2019-03-14 | |
| 2016-12-31 | $325.00K 10-K · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |